SavedAdd your journal

Journals / Kadın Doğum Dergisi / 2006 / Cilt: 4 - Sayı: 4

Stage IB2 cervical cancer treatment: Current approach

Evre IB2 serviks kanserinde tedaviye güncel yaklaşım

Aslı YARCI
Murat SÖNMEZER
Fırat ORTAÇ
Pages
958–964
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prognosis of early stage servical cancer (Stage IB, IIA

📌 3 Key Takeaways

🎯
Objective & Hypothesis:ABSTRACT Inspite of widespread screening programes, cervical cancer continues to be an important cause of morbidity.
📊
Key Findings & Data:Mean age of diagnosis is 52.2 years but incidence of cervical cancer increases mostly at third and sixth decade.
💡
Conclusion & Impact:Prognosis of early stage servical cancer (Stage IB, IIA
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

ABSTRACT Inspite of widespread screening programes, cervical cancer continues to be an important cause of morbidity. Mean age of diagnosis is 52.2 years but incidence of cervical cancer increases mostly at third and sixth decade. Since this malignancy affects a younger population; an average of 26 years of life are lost in each patient atfected(l,3). Prognosis of early stage servical cancer (Stage IB, IIA

Özet

Serviks kanseri, tarama programlarının yaygınlığına rağmen, önemli bir morbidite sebebi olmaya devam etmektedir. Ortalama 52.2 yaşında görülmekle birlikte, serviks kanseri insidansı 30'lu ve 60'lı yaşların ortalarında olmak üzere iki kez pik yapmaktadır. Daha genç bir populasyonu etkilediğinden, hastaların yaşamından ortalama 26 yılın kaybolmasına sebep olmaktadır (1,3). Erken evre serviks kanseri (Evre IB„ HA

🔖

Cite This Article

YARCI, A., SÖNMEZER, M., ORTAÇ, F. (2022). Stage IB2 cervical cancer treatment: Current approach. Kadın Doğum Dergisi, Cilt: 4 - Sayı: 4, 958–964. https://ajindex.com/articles/569008

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Jonathan S. Berek. Novak Jiııekololoji 13. baskı, Nobel Tıp Kitabevi, Ankara 2004, pp 1199-1244 2-DiSaia PJ, Creasman WT. Invasive cervical cancer. DiSaia PJ, Creasman WT (Ed). Clinical Gynecologic Oncology Saunders Yayinevi, 6th edn, New York 2002
  2. 111 3-Rose PG. Chemoradiotherapy for cervical cancer.,European Journal ot'Cancer 2002
  3. 278 4-Benedet JL, Bender H, Jones 111 H, Ngan HYS, Pecorelli S. Staging classifications and clinical practice guidelines of gynaecologic cancers
  4. F1GO. Int J Gynecol Obstet 2000
  5. 312 5-Herzog TJ. New approaches for the management of cervical cancer. GynecolOncol 2003
  6. 2227 6-Shepherd JH, FRCS, FRCOG, FACOG. Uterus-conserving surgery for invasivecervical cancer.Best Practice & Research Clinical Obstetrics and Gynaecology 2005
  7. 577590. 7-Hockel M, DornhoferN. How to manage locally advanced primary and recurrentcancer of the uterine cervix: The surgeon's view. Reviews in Gynaecological Practice 2005
  8. 220 8-Finan MA, Decesare S, Fiorica JV, Chambers R, Hoffman MS, Kline RC, Roberts WS, Cavanagh D. Radical Hysterectomy for Stage IB1 vs IB2 Carcinoma of theCervix:Does the New Staging System Predict Morbidity and Survival? Gynecol Oncol 1996
  9. 147 9-Landoni F, ManeoA, ColomboA, PlacaF, Milani R, Perego F, Favini G, Feri L, Mangioni C. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997
  10. 53540 10-Keys HM, Bundy BN, Stehman FB, Munderspach LI, Chafe WE, Suggs CL, Walker JL, Gersell D, Cisplatin, Radiation, and adjuvant hysterectomy compared with radiatoin and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New Engl J Med 1999,340: 15: 1154-61 11-Grigsby PW, M.B.A. FACR. Stage IB 1 vs IB2 Carcinoma of the Cervix: Should the New FIGO Staging System Define Therapy? Gynecol Oncol 1996
  11. 135136 12-Yessaian A, Magistris A, Burger RA, Monk BJ. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indicationsfor adjuvant therapy. Gynecologic Oncology 2004
  12. 616 13-Dreyer G. Operative management of cervical cancer. Best Practice & Research Clinical Obstetrics and Gynaecology 2005
  13. 576 14-Havrilesky LJ, Leath CA, Huh W, Calingaert B, Bentley RC, Soper JT, SecordAA, Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. Gynecol Oncol 2004
  14. 429434 15-Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. ARandomized Trial of